PS

Poornima Sengar

Active Director Director DIN 10890105
DIN 10890105 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Poornima Sengar

Data last updated:

Poornima Sengar is a Director at Ragi Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10890105
Primary Designation Director
Industry Pharma
First Appointment 29 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ragi Pharmaceuticals Private Limited U47721MH2025PTC439215
Director29 Jan 20252025Active

Board colleagues of Poornima Sengar

NameDINCompanyDesignation
Arya Sengar10889891Ragi Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ragi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poornima Sengar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poornima Sengar

Poornima Sengar currently holds 1 directorship: Ragi Pharmaceuticals Private Limited (Director, since 29 Jan 2025).

Poornima Sengar was first appointed on 29 Jan 2025 as Director at Ragi Pharmaceuticals Private Limited.

The current boards of Poornima Sengar's companies include Arya Sengar (Ragi Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available